
BioGaia´s history goes back to the 1980´s, at the time when HIV was discovered.
Two scientists, Sven Lindgren and Walt Dobrogosz were investigated different probiotics in order to see what effects they had.
They found many important properties and positive effects with Lactobacillus reuteri.
At the same time, two Swedish entrepreneurs, Peter Rothschild and Jan Annwall, imported organic vegetables and exclusive yoghurt from France to Sweden.
They were looking for an alternative way of preserving the vegetables during the long trip.
Read more about BioGaias history here.
Milestones
All events marked with an * is when BioGaia has been first on the market with a product.
-
1990: Foundation of BioGaia
-
1991: Launch of the first functional food product containing BioGaia probiotics
-
1993: First patent on L. reuteri granted
-
1995: First L. reuteri clinical trial in humans published
-
1997: The unique LifeTop cap bottle closure was developed *
-
1997: Launch of the first probiotic fresh juice and fresh cheese with L. reuteri *
-
1998: BioGaia listed on the Stockholm Stock Exchange
-
2000: BioGaia launches the first probiotic chewable tablet in the world *
-
2001: The first Probiotic infant formula with L. reuteri is introduced onto the market. * Patent for BioGaia Probiotic Straw (former LifeTop Straw), the first Probiotic drinking straw, is approved
-
2002: Launch of the first Probiotic straw in the world *
-
2004: The world's first Probiotic drops and oral health products are launched. Over one billion daily doses of L. reuteri sold globally *
-
2006: Launch of the BioGaia brand
-
2007: L. reuteri shown to significantly reduce crying time in infants with colic
-
2008: Over 50 studies with L. reuteri in more than 4,000 subjects. Global agreement with Nestlé Nutrition for infant baby formula. BioGaia products sold in more than 40 countries
-
2009: Launch of the BioGaia Probiotic oral rehydration solution (ORS) containing L. reuteri. The first ORS containing probiotics and zink *
-
2010: Three billion doses sold globally. 80 studies carried out on over 5,000 individuals. BioGaia’s products sold in more than 60 countries. BioGaia celebrates 20 years as a successful probiotics company
-
2011: BioGaia goes from listed as Small Cap to Mid Cap at NASDAQ OMX Nordic Exchange Stockholm.




